D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Amazon
AMZN
|
$1.02B |
| 2 |
Tesla
TSLA
|
$451M |
| 3 |
Wells Fargo
WFC
|
$433M |
| 4 |
Procter & Gamble
PG
|
$359M |
| 5 |
Meta Platforms (Facebook)
META
|
$342M |
Top Sells
| 1 |
Shopify
SHOP
|
$523M |
| 2 |
Adobe
ADBE
|
$373M |
| 3 |
DocuSign
DOCU
|
$312M |
| 4 |
Exxon Mobil
XOM
|
$285M |
| 5 |
Citigroup
C
|
$260M |
Sector Composition
| 1 | Technology | 22.42% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Healthcare | 12.61% |
| 4 | Financials | 9.46% |
| 5 | Communication Services | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Goodyear
GT
$2.43B
| $57.6M | 0.07% |
6,439,743
+714,496
| +12% | +$6.39M |
|
227
Pure Storage
PSTG
$25.9B
| $56.9M | 0.07% |
3,283,278
+388,431
| +13% | +$6.73M |
|
228
EOG Resources
EOG
$64.4B
| $56.7M | 0.07% |
1,120,095
-1,994,903
| -64% | -$101M |
|
229
Karyopharm Therapeutics
KPTI
$57.2M
| $56.3M | 0.07% |
198,334
+38,082
| +24% | +$10.8M |
|
230
Halozyme
HALO
$8.76B
| $56.3M | 0.07% |
2,100,886
+197,293
| +10% | +$5.29M |
|
231
Dover
DOV
$24.4B
| $56M | 0.07% |
580,236
+206,031
| +55% | +$19.9M |
|
|
AMED
232
DELISTED
Amedisys
AMED
| $55.7M | 0.07% |
280,446
-167,387
| -37% | -$33.2M |
|
233
Under Armour
UAA
$2.2B
| $55M | 0.07% |
5,646,697
+2,722,774
| +93% | +$26.5M |
|
234
Fiserv
FI
$73.4B
| $53.8M | 0.06% |
551,163
+537,863
| +4,044% | +$52.5M |
|
235
The Mosaic Company
MOS
$10.3B
| $53.7M | 0.06% |
4,292,404
+2,476,603
| +136% | +$31M |
|
236
Tenable Holdings
TENB
$3.76B
| $53.6M | 0.06% |
1,798,687
+119,689
| +7% | +$3.57M |
|
237
Verisk Analytics
VRSK
$37.8B
| $52.4M | 0.06% |
307,704
+66,838
| +28% | +$11.4M |
|
238
Trip.com Group
TCOM
$47.6B
| $52.3M | 0.06% |
2,019,112
-824,611
| -29% | -$21.4M |
|
239
Thomson Reuters
TRI
$78.7B
| $52.1M | 0.06% |
738,794
+368,984
| +100% | +$26M |
|
240
Amgen
AMGN
$153B
| $52.1M | 0.06% |
220,700
-711,280
| -76% | -$168M |
|
241
CrowdStrike
CRWD
$105B
| $51.7M | 0.06% |
515,955
-41,812
| -7% | -$4.19M |
|
242
Pacira BioSciences
PCRX
$1.19B
| $50.9M | 0.06% |
970,385
-76,598
| -7% | -$4.02M |
|
243
Akamai
AKAM
$11.3B
| $50.5M | 0.06% |
471,657
-474,068
| -50% | -$50.8M |
|
244
Trane Technologies
TT
$92.1B
| $50.1M | 0.06% |
562,608
-85,683
| -13% | -$7.62M |
|
245
Fortive
FTV
$16.2B
| $49.9M | 0.06% |
881,334
-354,878
| -29% | -$20.1M |
|
246
Lyft
LYFT
$6.91B
| $49.8M | 0.06% |
1,508,976
+1,103,190
| +272% | +$36.4M |
|
247
Graphic Packaging
GPK
$6.38B
| $49.5M | 0.06% |
3,535,468
-170,026
| -5% | -$2.38M |
|
248
Devon Energy
DVN
$22.1B
| $49.4M | 0.06% |
4,358,558
-209,952
| -5% | -$2.38M |
|
|
AVLR
249
DELISTED
Avalara, Inc.
AVLR
| $49.2M | 0.06% |
369,437
-586,549
| -61% | -$78.1M |
|
250
Inspire Medical Systems
INSP
$2.56B
| $48.7M | 0.06% |
559,683
+135,413
| +32% | +$11.8M |
|